Tony Hodges
Directeur Technique/Scientifique/R&D chez LA JOLLA PHARMACEUTICAL COMPANY
Profil
Tony Hodges is currently the Chief Medical Officer at La Jolla Pharmaceutical Co. Prior to this, he worked as the Director of Lung Transplantation at The Banner-University Medical Center from 2016 to 2020.
He also served as the Medical Director of Lung Transplantation at Keck Medicine of USC and Norton Thoracic Institute.
Mr. Hodges received his undergraduate degree from Louisiana Tech University and his doctorate from LSU Medical School.
Postes actifs de Tony Hodges
| Sociétés | Poste | Début |
|---|---|---|
| LA JOLLA PHARMACEUTICAL COMPANY | Directeur Technique/Scientifique/R&D | 12/09/2021 |
Anciens postes connus de Tony Hodges
| Sociétés | Poste | Fin |
|---|---|---|
| The Banner-University Medical Center | Corporate Officer/Principal | 01/01/2020 |
| Keck Medicine of USC | Corporate Officer/Principal | - |
| Norton Thoracic Institute | Corporate Officer/Principal | - |
Formation de Tony Hodges
| Louisiana Tech University | Undergraduate Degree |
| Lsu Medical School | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
La Jolla Pharmaceutical Co.
 La Jolla Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology La Jolla Pharmaceutical Co. operates as a biopharmaceutical company. It engages in the discovery, development and commercialization of therapies intended to improve outcomes in patients suffering from life-threatening diseases. Its products portfolio include GIAPREZA and XERAVA. The company was founded in 1989 and is headquartered in San Diego, CA. | Health Technology |
| Norton Thoracic Institute |
